Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Catalyst Pharmaceuticals, Inc. | StockGist | StockGist

Companies
CPRX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CPRXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Catalyst Pharmaceuticals, Inc.

Filed Feb 13, 2025

Accepted Feb 12, 2025, 7:00 PM ET

CIK 0001369568

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

10

Reporting Person

CATALYST PHARMACEUTICALS, INC.

Person Type

PN

CUSIP: 14888U101

Amendment History

4 filings

SCHEDULE 13G
Original
Nov 10, 20250000093751-25-000584
SCHEDULE 13G/A
Amendment 1
Viewing
Feb 13, 20250001193805-25-000175
SCHEDULE 13G/A
Amendment 2
Apr 28, 20250002052113-25-001776
SCHEDULE 13G/A
Amendment 3
Latest
Mar 26, 20260000102909-26-000892

Key Facts

Shares Owned

10

Recent Filings

Catalyst Pharmaceuticals, Inc.1 weeks ago

Catalyst Pharmaceuticals, Inc.2 weeks ago

Catalyst Pharmaceuticals, Inc.1 months ago

Catalyst Pharmaceuticals, Inc.1 months ago

Catalyst Pharmaceuticals, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice